Transdermal drug administration involves delivering medications through the skin into the bloodstream. This route utilizes specially designed patches or topical preparations that allow drugs to penetrate through skin layers for systemic effects. It offers unique advantages in maintaining steady drug levels over extended periods.
Forms of Transdermal Medications
- Patches: Adhesive systems containing drug reservoirs
- Gels: Semi-solid preparations for skin application
- Creams: Emulsion-based preparations
- Solutions: Liquid preparations for skin application
- Spray formulations: Aerosolized medications
Advantages
- Consistent drug levels
- Bypass first-pass metabolism
- Extended release possible
- Non-invasive administration
- Easy to discontinue
- Reduced dosing frequency
- Good compliance
- Avoids gastrointestinal issues
Disadvantages
- Limited drug options
- Skin irritation possible
- Variable absorption rates
- Weather/temperature effects
- Adhesion problems
- Higher cost than oral forms
- May be visible
- Limited dose flexibility
Best Practices
- Clean and dry skin before application
- Rotate application sites
- Remove old patches completely
- Check for skin reactions
- Follow replacement schedules
- Proper disposal of used patches
- Protect from heat/water exposure
Special Considerations
- Skin condition and integrity
- Environmental factors
- Physical activity levels
- Swimming/bathing impacts
- Patch visibility concerns
- Cost factors
- Storage requirements
- Drug abuse potential
Transdermal Patch Design and Permeation Factors
Transdermal patches consist of several layers: an impermeable backing film, a drug reservoir or matrix, an adhesive layer, and a release liner. Reservoir patches (e.g., estradiol) contain the drug in a liquid or gel reservoir, while matrix patches (e.g., nicotine) have the drug dispersed in a polymer matrix, offering better control and safety. Drug permeation through the skin follows Fick’s law of diffusion: flux = D × K × ΔC / h, where D is the diffusion coefficient, K is the partition coefficient, ΔC is the concentration gradient, and h is the membrane thickness. Only drugs with molecular weight < 500 Da, log P between 1–3, and daily dose < 10 mg are suitable for transdermal delivery. Nicotine patches (7–21 mg/24 h) help smoking cessation by providing steady plasma levels; fentanyl patches (12–100 µg/h) deliver potent opioid analgesia for 72 hours for chronic pain. Application sites should be rotated between the upper arm, chest, back, and abdomen to minimize irritation — the same site should not be used for 7 days. Heat exposure (heating pads, fever, hot baths) increases drug absorption by 10–40% and can lead to dangerous overdose with fentanyl. Used patches contain residual drug and must be folded in half (adhesive sides together) and disposed of according to controlled substance guidelines.
Conclusion
Transdermal drug delivery offers unique advantages for specific medications and patient populations. Success relies on proper patient selection, education about application techniques, and attention to factors affecting drug absorption through the skin.
